Comparison of extent of tau pathology in patients with frontotemporal dementia with Parkinsonism linked to chromosome 17 (FTDP-17), frontotemporal lobar degeneration with Pick bodies and early onset Alzheimer's disease

In order to gain insight into the pathogenesis of frontotemporal lobar degeneration (FTLD), the mean tau load in frontal cortex was compared in 34 patients with frontotemporal dementia linked to chromosome 17 (FTDP‐17) with 12 different mutations in the tau gene (MAPT), 11 patients with sporadic FTL...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Neuropathology and applied neurobiology 2006-08, Vol.32 (4), p.374-387
Hauptverfasser: Shiarli, A.-M., Jennings, R., Shi, J., Bailey, K., Davidson, Y., Tian, J., Bigio, E. H., Ghetti, B., Murrell, J. R., Delisle, M. B., Mirra, S., Crain, B., Zolo, P., Arima, K., Iseki, E., Murayama, S., Kretzschmar, H., Neumann, M., Lippa, C., Halliday, G., MacKenzie, J., Khan, N., Ravid, R., Dickson, D., Wszolek, Z., Iwatsubo, T., Pickering-Brown, S. M., Mann, D. M. A.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 387
container_issue 4
container_start_page 374
container_title Neuropathology and applied neurobiology
container_volume 32
creator Shiarli, A.-M.
Jennings, R.
Shi, J.
Bailey, K.
Davidson, Y.
Tian, J.
Bigio, E. H.
Ghetti, B.
Murrell, J. R.
Delisle, M. B.
Mirra, S.
Crain, B.
Zolo, P.
Arima, K.
Iseki, E.
Murayama, S.
Kretzschmar, H.
Neumann, M.
Lippa, C.
Halliday, G.
MacKenzie, J.
Khan, N.
Ravid, R.
Dickson, D.
Wszolek, Z.
Iwatsubo, T.
Pickering-Brown, S. M.
Mann, D. M. A.
description In order to gain insight into the pathogenesis of frontotemporal lobar degeneration (FTLD), the mean tau load in frontal cortex was compared in 34 patients with frontotemporal dementia linked to chromosome 17 (FTDP‐17) with 12 different mutations in the tau gene (MAPT), 11 patients with sporadic FTLD with Pick bodies and 25 patients with early onset Alzheimer’s disease (EOAD). Tau load was determined, as percentage of tissue occupied by stained product, by image analysis of immunohistochemically stained sections using the phospho‐dependent antibodies AT8, AT100 and AT180. With AT8 and AT180 antibodies, the amount of tau was significantly (P 
doi_str_mv 10.1111/j.1365-2990.2006.00736.x
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_68678567</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>68678567</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4656-792f55c9f045729c2f24b7f7ea77aa5606d4317bd4a59545ca5b7cb8bb36abea3</originalsourceid><addsrcrecordid>eNqNUs2O0zAQjhCILQuvgHzhTyLFTmI7kfZSFbaAqrKHRUhcrEky2bp14mKn2pZH5WlwSLUrcQFfbOv7mdHMF0WE0SkL591mylLB46Qo6DShVEwplamYHh5EkzvgYTShKeUxyzNxFj3xfkMp5VIUj6MzJnIhijydRL_mtt2B0952xDYEDz12_fDqYU920K-tsTdHorvhowPmya3u16Rxtuttj-3OOjCkxjZgGkbwCtxWd8FS-5YY3W2xJr0l1drZ1nrbImGSvL68fn8VM_nm7d9mxpbgguUNduhC1dDaaKurLSltrdET6GqC4MyR2M5jT2bm5xp1i-6VJ7X2CB6fRo8aMB6fne7z6Ovlh-v5x3j5ZfFpPlvGVSa4iGWRNJxXRUMzLpOiSpokK2UjEaQE4IKKOkuZLOsMeMEzXgEvZVXmZZkKKBHS8-jl6Ltz9scefa9a7Ss0Bjq0e6_CrGXOhfwnkRVZmudpHoj5SKyc9d5ho3ZOt-COilE1BEBt1LBnNexZDQFQfwKgDkH6_FRjX7ZY3wtPGw-EFycC-ApM46CrtL_nySJjCWeBdzHybrXB4383oFazVXgEeTzKte_xcCcPwVBhEpKrb6uFWsjvnC0pVZ_T39DC36E</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>19438838</pqid></control><display><type>article</type><title>Comparison of extent of tau pathology in patients with frontotemporal dementia with Parkinsonism linked to chromosome 17 (FTDP-17), frontotemporal lobar degeneration with Pick bodies and early onset Alzheimer's disease</title><source>Wiley-Blackwell Journals</source><source>MEDLINE</source><creator>Shiarli, A.-M. ; Jennings, R. ; Shi, J. ; Bailey, K. ; Davidson, Y. ; Tian, J. ; Bigio, E. H. ; Ghetti, B. ; Murrell, J. R. ; Delisle, M. B. ; Mirra, S. ; Crain, B. ; Zolo, P. ; Arima, K. ; Iseki, E. ; Murayama, S. ; Kretzschmar, H. ; Neumann, M. ; Lippa, C. ; Halliday, G. ; MacKenzie, J. ; Khan, N. ; Ravid, R. ; Dickson, D. ; Wszolek, Z. ; Iwatsubo, T. ; Pickering-Brown, S. M. ; Mann, D. M. A.</creator><creatorcontrib>Shiarli, A.-M. ; Jennings, R. ; Shi, J. ; Bailey, K. ; Davidson, Y. ; Tian, J. ; Bigio, E. H. ; Ghetti, B. ; Murrell, J. R. ; Delisle, M. B. ; Mirra, S. ; Crain, B. ; Zolo, P. ; Arima, K. ; Iseki, E. ; Murayama, S. ; Kretzschmar, H. ; Neumann, M. ; Lippa, C. ; Halliday, G. ; MacKenzie, J. ; Khan, N. ; Ravid, R. ; Dickson, D. ; Wszolek, Z. ; Iwatsubo, T. ; Pickering-Brown, S. M. ; Mann, D. M. A.</creatorcontrib><description>In order to gain insight into the pathogenesis of frontotemporal lobar degeneration (FTLD), the mean tau load in frontal cortex was compared in 34 patients with frontotemporal dementia linked to chromosome 17 (FTDP‐17) with 12 different mutations in the tau gene (MAPT), 11 patients with sporadic FTLD with Pick bodies and 25 patients with early onset Alzheimer’s disease (EOAD). Tau load was determined, as percentage of tissue occupied by stained product, by image analysis of immunohistochemically stained sections using the phospho‐dependent antibodies AT8, AT100 and AT180. With AT8 and AT180 antibodies, the amount of tau was significantly (P &lt; 0.001 in each instance) less than that in EOAD for both FTDP‐17 (8.5% and 10.0% respectively) and sporadic FTLD with Pick bodies (16.1% and 10.0% respectively). With AT100, the amount of tau detected in FTDP‐17 was 54% (P &lt; 0.001) of that detected in EOAD, but no tau was detected in sporadic FTLD with Pick bodies using this particular antibody. The amount of insoluble tau deposited within the brain in FTDP‐17 did not depend in any systematic way upon where the MAPT mutation was topographically located within the gene, or on the physiological or structural change generated by the mutation, regardless of which anti‐tau antibody was used. Not only does the amount of tau deposited in the brain differ between the three disorders, but the pattern of phosphorylation of tau also varies according to disease. These findings raise important questions relating to the role of aggregated tau in neurodegeneration – whether this represents an adaptive response which promotes the survival of neurones, or whether it is a detrimental change that directly, or indirectly, brings about the demize of the affected cell.</description><identifier>ISSN: 0305-1846</identifier><identifier>EISSN: 1365-2990</identifier><identifier>DOI: 10.1111/j.1365-2990.2006.00736.x</identifier><identifier>PMID: 16866983</identifier><identifier>CODEN: NANEDL</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Publishing Ltd</publisher><subject>Adult ; Age of Onset ; Aged ; Alzheimer Disease - genetics ; Alzheimer Disease - pathology ; Alzheimer's disease ; Apolipoproteins E - genetics ; Biological and medical sciences ; Brain - pathology ; Chromosomes, Human, Pair 17 ; Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases ; Dementia - genetics ; Dementia - pathology ; Female ; frontotemporal lobar degeneration ; Genotype ; Human viral diseases ; Humans ; Image Processing, Computer-Assisted ; Immunohistochemistry ; Infectious diseases ; Male ; Medical sciences ; Microtubule-Associated Proteins - genetics ; Middle Aged ; Nerve Tissue Proteins - genetics ; neurofibrillary tangle ; Neurology ; Parkinsonian Disorders - genetics ; Parkinsonian Disorders - pathology ; Pick bodies ; Pick Disease of the Brain - genetics ; Pick Disease of the Brain - pathology ; Tau gene ; Tau protein ; tau Proteins - metabolism ; Viral diseases ; Viral diseases of the nervous system</subject><ispartof>Neuropathology and applied neurobiology, 2006-08, Vol.32 (4), p.374-387</ispartof><rights>2006 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4656-792f55c9f045729c2f24b7f7ea77aa5606d4317bd4a59545ca5b7cb8bb36abea3</citedby><cites>FETCH-LOGICAL-c4656-792f55c9f045729c2f24b7f7ea77aa5606d4317bd4a59545ca5b7cb8bb36abea3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fj.1365-2990.2006.00736.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fj.1365-2990.2006.00736.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1416,27922,27923,45572,45573</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=17941251$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16866983$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Shiarli, A.-M.</creatorcontrib><creatorcontrib>Jennings, R.</creatorcontrib><creatorcontrib>Shi, J.</creatorcontrib><creatorcontrib>Bailey, K.</creatorcontrib><creatorcontrib>Davidson, Y.</creatorcontrib><creatorcontrib>Tian, J.</creatorcontrib><creatorcontrib>Bigio, E. H.</creatorcontrib><creatorcontrib>Ghetti, B.</creatorcontrib><creatorcontrib>Murrell, J. R.</creatorcontrib><creatorcontrib>Delisle, M. B.</creatorcontrib><creatorcontrib>Mirra, S.</creatorcontrib><creatorcontrib>Crain, B.</creatorcontrib><creatorcontrib>Zolo, P.</creatorcontrib><creatorcontrib>Arima, K.</creatorcontrib><creatorcontrib>Iseki, E.</creatorcontrib><creatorcontrib>Murayama, S.</creatorcontrib><creatorcontrib>Kretzschmar, H.</creatorcontrib><creatorcontrib>Neumann, M.</creatorcontrib><creatorcontrib>Lippa, C.</creatorcontrib><creatorcontrib>Halliday, G.</creatorcontrib><creatorcontrib>MacKenzie, J.</creatorcontrib><creatorcontrib>Khan, N.</creatorcontrib><creatorcontrib>Ravid, R.</creatorcontrib><creatorcontrib>Dickson, D.</creatorcontrib><creatorcontrib>Wszolek, Z.</creatorcontrib><creatorcontrib>Iwatsubo, T.</creatorcontrib><creatorcontrib>Pickering-Brown, S. M.</creatorcontrib><creatorcontrib>Mann, D. M. A.</creatorcontrib><title>Comparison of extent of tau pathology in patients with frontotemporal dementia with Parkinsonism linked to chromosome 17 (FTDP-17), frontotemporal lobar degeneration with Pick bodies and early onset Alzheimer's disease</title><title>Neuropathology and applied neurobiology</title><addtitle>Neuropathol Appl Neurobiol</addtitle><description>In order to gain insight into the pathogenesis of frontotemporal lobar degeneration (FTLD), the mean tau load in frontal cortex was compared in 34 patients with frontotemporal dementia linked to chromosome 17 (FTDP‐17) with 12 different mutations in the tau gene (MAPT), 11 patients with sporadic FTLD with Pick bodies and 25 patients with early onset Alzheimer’s disease (EOAD). Tau load was determined, as percentage of tissue occupied by stained product, by image analysis of immunohistochemically stained sections using the phospho‐dependent antibodies AT8, AT100 and AT180. With AT8 and AT180 antibodies, the amount of tau was significantly (P &lt; 0.001 in each instance) less than that in EOAD for both FTDP‐17 (8.5% and 10.0% respectively) and sporadic FTLD with Pick bodies (16.1% and 10.0% respectively). With AT100, the amount of tau detected in FTDP‐17 was 54% (P &lt; 0.001) of that detected in EOAD, but no tau was detected in sporadic FTLD with Pick bodies using this particular antibody. The amount of insoluble tau deposited within the brain in FTDP‐17 did not depend in any systematic way upon where the MAPT mutation was topographically located within the gene, or on the physiological or structural change generated by the mutation, regardless of which anti‐tau antibody was used. Not only does the amount of tau deposited in the brain differ between the three disorders, but the pattern of phosphorylation of tau also varies according to disease. These findings raise important questions relating to the role of aggregated tau in neurodegeneration – whether this represents an adaptive response which promotes the survival of neurones, or whether it is a detrimental change that directly, or indirectly, brings about the demize of the affected cell.</description><subject>Adult</subject><subject>Age of Onset</subject><subject>Aged</subject><subject>Alzheimer Disease - genetics</subject><subject>Alzheimer Disease - pathology</subject><subject>Alzheimer's disease</subject><subject>Apolipoproteins E - genetics</subject><subject>Biological and medical sciences</subject><subject>Brain - pathology</subject><subject>Chromosomes, Human, Pair 17</subject><subject>Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases</subject><subject>Dementia - genetics</subject><subject>Dementia - pathology</subject><subject>Female</subject><subject>frontotemporal lobar degeneration</subject><subject>Genotype</subject><subject>Human viral diseases</subject><subject>Humans</subject><subject>Image Processing, Computer-Assisted</subject><subject>Immunohistochemistry</subject><subject>Infectious diseases</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Microtubule-Associated Proteins - genetics</subject><subject>Middle Aged</subject><subject>Nerve Tissue Proteins - genetics</subject><subject>neurofibrillary tangle</subject><subject>Neurology</subject><subject>Parkinsonian Disorders - genetics</subject><subject>Parkinsonian Disorders - pathology</subject><subject>Pick bodies</subject><subject>Pick Disease of the Brain - genetics</subject><subject>Pick Disease of the Brain - pathology</subject><subject>Tau gene</subject><subject>Tau protein</subject><subject>tau Proteins - metabolism</subject><subject>Viral diseases</subject><subject>Viral diseases of the nervous system</subject><issn>0305-1846</issn><issn>1365-2990</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNUs2O0zAQjhCILQuvgHzhTyLFTmI7kfZSFbaAqrKHRUhcrEky2bp14mKn2pZH5WlwSLUrcQFfbOv7mdHMF0WE0SkL591mylLB46Qo6DShVEwplamYHh5EkzvgYTShKeUxyzNxFj3xfkMp5VIUj6MzJnIhijydRL_mtt2B0952xDYEDz12_fDqYU920K-tsTdHorvhowPmya3u16Rxtuttj-3OOjCkxjZgGkbwCtxWd8FS-5YY3W2xJr0l1drZ1nrbImGSvL68fn8VM_nm7d9mxpbgguUNduhC1dDaaKurLSltrdET6GqC4MyR2M5jT2bm5xp1i-6VJ7X2CB6fRo8aMB6fne7z6Ovlh-v5x3j5ZfFpPlvGVSa4iGWRNJxXRUMzLpOiSpokK2UjEaQE4IKKOkuZLOsMeMEzXgEvZVXmZZkKKBHS8-jl6Ltz9scefa9a7Ss0Bjq0e6_CrGXOhfwnkRVZmudpHoj5SKyc9d5ho3ZOt-COilE1BEBt1LBnNexZDQFQfwKgDkH6_FRjX7ZY3wtPGw-EFycC-ApM46CrtL_nySJjCWeBdzHybrXB4383oFazVXgEeTzKte_xcCcPwVBhEpKrb6uFWsjvnC0pVZ_T39DC36E</recordid><startdate>200608</startdate><enddate>200608</enddate><creator>Shiarli, A.-M.</creator><creator>Jennings, R.</creator><creator>Shi, J.</creator><creator>Bailey, K.</creator><creator>Davidson, Y.</creator><creator>Tian, J.</creator><creator>Bigio, E. H.</creator><creator>Ghetti, B.</creator><creator>Murrell, J. R.</creator><creator>Delisle, M. B.</creator><creator>Mirra, S.</creator><creator>Crain, B.</creator><creator>Zolo, P.</creator><creator>Arima, K.</creator><creator>Iseki, E.</creator><creator>Murayama, S.</creator><creator>Kretzschmar, H.</creator><creator>Neumann, M.</creator><creator>Lippa, C.</creator><creator>Halliday, G.</creator><creator>MacKenzie, J.</creator><creator>Khan, N.</creator><creator>Ravid, R.</creator><creator>Dickson, D.</creator><creator>Wszolek, Z.</creator><creator>Iwatsubo, T.</creator><creator>Pickering-Brown, S. M.</creator><creator>Mann, D. M. A.</creator><general>Blackwell Publishing Ltd</general><general>Blackwell Science</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope></search><sort><creationdate>200608</creationdate><title>Comparison of extent of tau pathology in patients with frontotemporal dementia with Parkinsonism linked to chromosome 17 (FTDP-17), frontotemporal lobar degeneration with Pick bodies and early onset Alzheimer's disease</title><author>Shiarli, A.-M. ; Jennings, R. ; Shi, J. ; Bailey, K. ; Davidson, Y. ; Tian, J. ; Bigio, E. H. ; Ghetti, B. ; Murrell, J. R. ; Delisle, M. B. ; Mirra, S. ; Crain, B. ; Zolo, P. ; Arima, K. ; Iseki, E. ; Murayama, S. ; Kretzschmar, H. ; Neumann, M. ; Lippa, C. ; Halliday, G. ; MacKenzie, J. ; Khan, N. ; Ravid, R. ; Dickson, D. ; Wszolek, Z. ; Iwatsubo, T. ; Pickering-Brown, S. M. ; Mann, D. M. A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4656-792f55c9f045729c2f24b7f7ea77aa5606d4317bd4a59545ca5b7cb8bb36abea3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Adult</topic><topic>Age of Onset</topic><topic>Aged</topic><topic>Alzheimer Disease - genetics</topic><topic>Alzheimer Disease - pathology</topic><topic>Alzheimer's disease</topic><topic>Apolipoproteins E - genetics</topic><topic>Biological and medical sciences</topic><topic>Brain - pathology</topic><topic>Chromosomes, Human, Pair 17</topic><topic>Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases</topic><topic>Dementia - genetics</topic><topic>Dementia - pathology</topic><topic>Female</topic><topic>frontotemporal lobar degeneration</topic><topic>Genotype</topic><topic>Human viral diseases</topic><topic>Humans</topic><topic>Image Processing, Computer-Assisted</topic><topic>Immunohistochemistry</topic><topic>Infectious diseases</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Microtubule-Associated Proteins - genetics</topic><topic>Middle Aged</topic><topic>Nerve Tissue Proteins - genetics</topic><topic>neurofibrillary tangle</topic><topic>Neurology</topic><topic>Parkinsonian Disorders - genetics</topic><topic>Parkinsonian Disorders - pathology</topic><topic>Pick bodies</topic><topic>Pick Disease of the Brain - genetics</topic><topic>Pick Disease of the Brain - pathology</topic><topic>Tau gene</topic><topic>Tau protein</topic><topic>tau Proteins - metabolism</topic><topic>Viral diseases</topic><topic>Viral diseases of the nervous system</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Shiarli, A.-M.</creatorcontrib><creatorcontrib>Jennings, R.</creatorcontrib><creatorcontrib>Shi, J.</creatorcontrib><creatorcontrib>Bailey, K.</creatorcontrib><creatorcontrib>Davidson, Y.</creatorcontrib><creatorcontrib>Tian, J.</creatorcontrib><creatorcontrib>Bigio, E. H.</creatorcontrib><creatorcontrib>Ghetti, B.</creatorcontrib><creatorcontrib>Murrell, J. R.</creatorcontrib><creatorcontrib>Delisle, M. B.</creatorcontrib><creatorcontrib>Mirra, S.</creatorcontrib><creatorcontrib>Crain, B.</creatorcontrib><creatorcontrib>Zolo, P.</creatorcontrib><creatorcontrib>Arima, K.</creatorcontrib><creatorcontrib>Iseki, E.</creatorcontrib><creatorcontrib>Murayama, S.</creatorcontrib><creatorcontrib>Kretzschmar, H.</creatorcontrib><creatorcontrib>Neumann, M.</creatorcontrib><creatorcontrib>Lippa, C.</creatorcontrib><creatorcontrib>Halliday, G.</creatorcontrib><creatorcontrib>MacKenzie, J.</creatorcontrib><creatorcontrib>Khan, N.</creatorcontrib><creatorcontrib>Ravid, R.</creatorcontrib><creatorcontrib>Dickson, D.</creatorcontrib><creatorcontrib>Wszolek, Z.</creatorcontrib><creatorcontrib>Iwatsubo, T.</creatorcontrib><creatorcontrib>Pickering-Brown, S. M.</creatorcontrib><creatorcontrib>Mann, D. M. A.</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Neuropathology and applied neurobiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Shiarli, A.-M.</au><au>Jennings, R.</au><au>Shi, J.</au><au>Bailey, K.</au><au>Davidson, Y.</au><au>Tian, J.</au><au>Bigio, E. H.</au><au>Ghetti, B.</au><au>Murrell, J. R.</au><au>Delisle, M. B.</au><au>Mirra, S.</au><au>Crain, B.</au><au>Zolo, P.</au><au>Arima, K.</au><au>Iseki, E.</au><au>Murayama, S.</au><au>Kretzschmar, H.</au><au>Neumann, M.</au><au>Lippa, C.</au><au>Halliday, G.</au><au>MacKenzie, J.</au><au>Khan, N.</au><au>Ravid, R.</au><au>Dickson, D.</au><au>Wszolek, Z.</au><au>Iwatsubo, T.</au><au>Pickering-Brown, S. M.</au><au>Mann, D. M. A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Comparison of extent of tau pathology in patients with frontotemporal dementia with Parkinsonism linked to chromosome 17 (FTDP-17), frontotemporal lobar degeneration with Pick bodies and early onset Alzheimer's disease</atitle><jtitle>Neuropathology and applied neurobiology</jtitle><addtitle>Neuropathol Appl Neurobiol</addtitle><date>2006-08</date><risdate>2006</risdate><volume>32</volume><issue>4</issue><spage>374</spage><epage>387</epage><pages>374-387</pages><issn>0305-1846</issn><eissn>1365-2990</eissn><coden>NANEDL</coden><abstract>In order to gain insight into the pathogenesis of frontotemporal lobar degeneration (FTLD), the mean tau load in frontal cortex was compared in 34 patients with frontotemporal dementia linked to chromosome 17 (FTDP‐17) with 12 different mutations in the tau gene (MAPT), 11 patients with sporadic FTLD with Pick bodies and 25 patients with early onset Alzheimer’s disease (EOAD). Tau load was determined, as percentage of tissue occupied by stained product, by image analysis of immunohistochemically stained sections using the phospho‐dependent antibodies AT8, AT100 and AT180. With AT8 and AT180 antibodies, the amount of tau was significantly (P &lt; 0.001 in each instance) less than that in EOAD for both FTDP‐17 (8.5% and 10.0% respectively) and sporadic FTLD with Pick bodies (16.1% and 10.0% respectively). With AT100, the amount of tau detected in FTDP‐17 was 54% (P &lt; 0.001) of that detected in EOAD, but no tau was detected in sporadic FTLD with Pick bodies using this particular antibody. The amount of insoluble tau deposited within the brain in FTDP‐17 did not depend in any systematic way upon where the MAPT mutation was topographically located within the gene, or on the physiological or structural change generated by the mutation, regardless of which anti‐tau antibody was used. Not only does the amount of tau deposited in the brain differ between the three disorders, but the pattern of phosphorylation of tau also varies according to disease. These findings raise important questions relating to the role of aggregated tau in neurodegeneration – whether this represents an adaptive response which promotes the survival of neurones, or whether it is a detrimental change that directly, or indirectly, brings about the demize of the affected cell.</abstract><cop>Oxford, UK</cop><pub>Blackwell Publishing Ltd</pub><pmid>16866983</pmid><doi>10.1111/j.1365-2990.2006.00736.x</doi><tpages>14</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0305-1846
ispartof Neuropathology and applied neurobiology, 2006-08, Vol.32 (4), p.374-387
issn 0305-1846
1365-2990
language eng
recordid cdi_proquest_miscellaneous_68678567
source Wiley-Blackwell Journals; MEDLINE
subjects Adult
Age of Onset
Aged
Alzheimer Disease - genetics
Alzheimer Disease - pathology
Alzheimer's disease
Apolipoproteins E - genetics
Biological and medical sciences
Brain - pathology
Chromosomes, Human, Pair 17
Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases
Dementia - genetics
Dementia - pathology
Female
frontotemporal lobar degeneration
Genotype
Human viral diseases
Humans
Image Processing, Computer-Assisted
Immunohistochemistry
Infectious diseases
Male
Medical sciences
Microtubule-Associated Proteins - genetics
Middle Aged
Nerve Tissue Proteins - genetics
neurofibrillary tangle
Neurology
Parkinsonian Disorders - genetics
Parkinsonian Disorders - pathology
Pick bodies
Pick Disease of the Brain - genetics
Pick Disease of the Brain - pathology
Tau gene
Tau protein
tau Proteins - metabolism
Viral diseases
Viral diseases of the nervous system
title Comparison of extent of tau pathology in patients with frontotemporal dementia with Parkinsonism linked to chromosome 17 (FTDP-17), frontotemporal lobar degeneration with Pick bodies and early onset Alzheimer's disease
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T15%3A21%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Comparison%20of%20extent%20of%20tau%20pathology%20in%20patients%20with%20frontotemporal%20dementia%20with%20Parkinsonism%20linked%20to%20chromosome%2017%20(FTDP-17),%20frontotemporal%20lobar%20degeneration%20with%20Pick%20bodies%20and%20early%20onset%20Alzheimer's%20disease&rft.jtitle=Neuropathology%20and%20applied%20neurobiology&rft.au=Shiarli,%20A.-M.&rft.date=2006-08&rft.volume=32&rft.issue=4&rft.spage=374&rft.epage=387&rft.pages=374-387&rft.issn=0305-1846&rft.eissn=1365-2990&rft.coden=NANEDL&rft_id=info:doi/10.1111/j.1365-2990.2006.00736.x&rft_dat=%3Cproquest_cross%3E68678567%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=19438838&rft_id=info:pmid/16866983&rfr_iscdi=true